U.S. Representative Val Demings (D-Florida) has announced she has been diagnosed with prostate cancer and is suspending her campaign for governor to focus on treatment. Demings shared the news in a statement that her cancer was caught early, and she expects a full recovery. The announcement underscores the importance of routine prostate cancer screening, especially for men over 50 and those with a family history.

Key Takeaways

  • U.S. Rep. Val Demings announced a prostate cancer diagnosis and is pausing her campaign for Florida governor.
  • Demings stated the cancer was detected early, and she anticipates a complete recovery after treatment.
  • Prostate cancer is one of the most common cancers in American men, but early detection greatly improves outcomes.
  • Health experts recommend regular PSA blood tests and digital rectal exams for men at average risk starting at age 50, or earlier for those at higher risk.
  • The announcement highlights the need for men to prioritize screening and discuss risk factors with their doctors.

Demings’ Announcement and Campaign Suspension

According to reports from WUSF, Demings released a written statement confirming her diagnosis. She said that during a routine medical visit, doctors found evidence of prostate cancer and that further tests confirmed the disease. Demings described the news as a setback but emphasized her hope for a full recovery. She has suspended all campaign activities for the Florida governor’s race effective immediately to concentrate on treatment.

Demings, who has served in the U.S. House of Representatives since 2017, previously ran for U.S. Senate in 2022. She was considered a leading Democratic candidate in the 2026 Florida gubernatorial election. Her decision to step back from the campaign trail demonstrates a focus on health over politics, a choice many public figures face when a serious illness arises.

Prostate Cancer: What to Know

Prostate cancer is the second most common cancer among American men, after skin cancer, according to the American Cancer Society. It typically grows slowly and often has no early symptoms. Many men are diagnosed after a blood test for prostate-specific antigen (PSA) or a digital rectal exam shows abnormalities. If caught early, the five year survival rate approaches 100 percent.

Risk factors include age (most cases occur in men over 50), family history of prostate or breast cancer, and African American ancestry. Demings is a Black woman, and while prostate cancer is most often discussed in cisgender men, it can occur in anyone with a prostate, including transgender women and nonbinary individuals. Black men have a higher incidence and mortality from prostate cancer, making regular screening especially important for this group.

Treatment and Prognosis

Treatment for prostate cancer depends on the stage and grade of the tumor. Options may include active surveillance (monitoring without immediate treatment), surgery, radiation therapy, hormone therapy, or chemotherapy. For early stage cancer, as Demings described, the outlook is generally excellent. Demings did not disclose her specific treatment plan, but stated she is confident in a full recovery.

Her announcement also serves as a reminder that cancer does not discriminate by political office or fame. Public figures who share their diagnosis often help reduce stigma and encourage others to get screened.

Frequently Asked Questions

What is prostate cancer?

Prostate cancer is a type of cancer that starts in the prostate, a small walnut shaped gland in men that produces seminal fluid. It is one of the most common forms of cancer and is often slow growing. Early detection through screening significantly improves treatment outcomes.

How is prostate cancer detected?

Prostate cancer is typically detected through a blood test that measures prostate-specific antigen (PSA) levels and a digital rectal exam. If either test is abnormal, a doctor may recommend a biopsy to confirm the presence of cancer. Routine screening is recommended starting at age 50 for average risk men, and earlier for those with a family history or African American heritage.

Can people with prostates who are not cisgender men get prostate cancer?

Yes. Anyone who has a prostate can develop prostate cancer, including transgender women and nonbinary individuals. Transgender women taking hormone therapy may still be at risk, and screening guidelines should be based on individual anatomy and risk factors. It is important for all individuals with a prostate to discuss screening with their healthcare provider.

This is an original report by Vital Signs Today, informed by reporting from Google News. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.